These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 32724793)
21. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions. Denina M; Pellegrino F; Morotti F; Coppo P; Bonsignori IM; Garazzino S; Ravanini P; Avolio M; Cavallo R; Bertolotti L; Felici E; Acucella G; Montin D; Rabbone I; Licciardi F J Am Acad Dermatol; 2020 Dec; 83(6):1751-1753. PubMed ID: 32781180 [No Abstract] [Full Text] [Related]
22. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases. Kanitakis J; Lesort C; Danset M; Jullien D J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585 [TBL] [Abstract][Full Text] [Related]
23. A dermatologic manifestation of COVID-19: Transient livedo reticularis. Manalo IF; Smith MK; Cheeley J; Jacobs R J Am Acad Dermatol; 2020 Aug; 83(2):700. PubMed ID: 32283229 [No Abstract] [Full Text] [Related]
24. Livedo reticularis and acrocyanosis as late manifestations of COVID-19 in two cases with familial aggregation. Potential pathogenic role of complement (C4c). García-Gil MF; Monte Serrano J; Lapeña-Casado A; García García M; Matovelle Ochoa C; Ara-Martín M Int J Dermatol; 2020 Dec; 59(12):1549-1551. PubMed ID: 33040378 [No Abstract] [Full Text] [Related]
25. Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Daneshgaran G; Dubin DP; Gould DJ Am J Clin Dermatol; 2020 Oct; 21(5):627-639. PubMed ID: 32865778 [TBL] [Abstract][Full Text] [Related]
26. A case of COVID-19 pneumonia presenting with acute urticaria. Naziroğlu T; Sözen S; Özkan P; Şeker S; Aksu K Dermatol Ther; 2020 Jul; 33(4):e13575. PubMed ID: 32401411 [No Abstract] [Full Text] [Related]
27. Chilblain-like lesions during the COVID-19 pandemic: early or late sign? Recalcati S; Fantini F Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958 [No Abstract] [Full Text] [Related]
28. COVID-19 skin manifestations: the new great imitator? Shi V; Hsiao JL; Shi VY Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342186 [No Abstract] [Full Text] [Related]
29. A unilateral purpuric rash in a patient with COVID-19 infection. Karaca Z; Yayli S; Çalışkan O Dermatol Ther; 2020 Jul; 33(4):e13798. PubMed ID: 32530130 [No Abstract] [Full Text] [Related]
30. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms. Altayeb A; Cordaro A; Caesar J; Vyas J; Ingram J Int J Dermatol; 2020 Dec; 59(12):1541-1542. PubMed ID: 33084036 [No Abstract] [Full Text] [Related]
31. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France. de Masson A; Bouaziz JD; Sulimovic L; Cassius C; Jachiet M; Ionescu MA; Rybojad M; Bagot M; Duong TA; J Am Acad Dermatol; 2020 Aug; 83(2):667-670. PubMed ID: 32380219 [No Abstract] [Full Text] [Related]
32. Chilblain-like lesions in children following suspected COVID-19 infection. Colonna C; Monzani NA; Rocchi A; Gianotti R; Boggio F; Gelmetti C Pediatr Dermatol; 2020 May; 37(3):437-440. PubMed ID: 32374033 [TBL] [Abstract][Full Text] [Related]
33. Cutaneous manifestations of COVID-19 in the Franche-Comté region of France: A monocentric study. Jacquin-Porretaz C; Ducournau A; Dupond AS; Nardin C; Aubin F; Courtieu C; Ann Dermatol Venereol; 2021 Jun; 148(2):124-126. PubMed ID: 33541738 [No Abstract] [Full Text] [Related]
34. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic. Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790 [No Abstract] [Full Text] [Related]
35. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. Nakashima C; Kato M; Otsuka A J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825 [TBL] [Abstract][Full Text] [Related]
36. New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus. Battesti G; El Khalifa J; Abdelhedi N; Ferre V; Bouscarat F; Picard-Dahan C; Brunet-Possenti F; Collin G; Lavaud J; Le Bozec P; Rousselot M; Tournier A; Lheure C; Couvelard A; Hacein-Bey-Abina S; Abina AM; Charpentier C; Mignot S; Nicaise P; Descamps D; Deschamps L; Descamps V J Am Acad Dermatol; 2020 Oct; 83(4):1219-1222. PubMed ID: 32622895 [No Abstract] [Full Text] [Related]
37. [What can we learn from the COVID-19 pandemic in general and about ourselves as dermatologists?]. Kluger N Ann Dermatol Venereol; 2020; 147(6-7):413-417. PubMed ID: 32414508 [No Abstract] [Full Text] [Related]
38. Viral exanthem with "Spins and needles sensation" on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner. Putra BE; Adiarto S; Dewayanti SR; Juzar DA Int J Infect Dis; 2020 Jul; 96():355-358. PubMed ID: 32437936 [TBL] [Abstract][Full Text] [Related]
39. Chilblains in children in the setting of COVID-19 pandemic. Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460 [TBL] [Abstract][Full Text] [Related]
40. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report. Ruggiero G; Arcangeli F; Lotti T Dermatol Ther; 2020 Jul; 33(4):e13616. PubMed ID: 32424851 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]